Education
About Us
Working with TipRanks
Follow Us
Johnson & Johnson (JNJ)
NYSE:JNJ
Earnings Data
Report Date
Jan 21, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
2.54Last Year’s EPS
2.04Same Quarter Last Year
Moderate Buy
Based on 21 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Johnson & Johnson demonstrated strong overall performance with significant growth across key segments and successful new product launches. Despite challenges from STELARA's loss of exclusivity and increased tax rates, the company's strategic focus and operational achievements suggest a positive outlook.Company Guidance
Strong Overall Financial Performance
Worldwide sales reached $24 billion for Q3 2025, with operational sales growth of 5.4%. Adjusted net earnings were $6.8 billion, a 15.7% increase compared to 2024.
Innovative Medicine Growth
Innovative Medicine reported 5.3% operational sales growth despite a 1070 basis point headwind from STELARA. Key brands like DARZALEX and TREMFYA showed double-digit growth.
MedTech Segment Expansion
MedTech achieved 5.6% operational sales growth with strong performance in cardiovascular and surgery segments. Cardiovascular operational sales increased by approximately 12%.
Successful New Product Launches
Highlights include the FDA approval for bladder cancer treatment Inlexo and significant growth in the launch of CARVICTI, which achieved sales of $524 million with 81.4% growth.
Orthopedics Business Separation
Johnson & Johnson announced the planned separation of its Orthopedics business, which is expected to enhance strategic focus and improve margins.
JNJ Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
JNJ Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 14, 2025 | $190.90 | $190.85 | -0.03% |
Jul 16, 2025 | $154.04 | $163.58 | +6.19% |
Apr 15, 2025 | $151.93 | $151.20 | -0.48% |
Jan 22, 2025 | $144.66 | $141.85 | -1.94% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Johnson & Johnson (JNJ) report earnings?
Johnson & Johnson (JNJ) is schdueled to report earning on Jan 21, 2026, Before Open (Confirmed).
What is Johnson & Johnson (JNJ) earnings time?
Johnson & Johnson (JNJ) earnings time is at Jan 21, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is JNJ EPS forecast?
JNJ EPS forecast for the fiscal quarter 2025 (Q4) is 2.54.
